During 2015 our main research efforts focused on:
- catheter ablation of atrial fibrillation: the FIRE & ICE Trial;
- new pacing technologies to set a new standard of care: the MICRA System.
The FIRE & ICE Trial, started in 2015, is a new controlled, prospective, non-inferiority, parallel-group, randomized, interventional, open and multi-center trial designed to compare the efficacy and safety of isolating the pulmonary veins with either the cryoballoon or a radiofrequency current (RFC) ablation technique with a THERMOCOOL catheter, a system which can be regarded as standard for ablation, in patients with paroxysmal atrial fibrillation.
The MICRA Transcatheter Pacing System (TPS) is a miniaturized (0.8 cc), leadless, full featured single chamber ventricular pacemaker that is implanted directly in the right ventricle. It provides a treatment options for patients with Class I or Class II indication for bradycardia pacing therapy.